Limited Antitumor T Cell Response in Melanoma Patients Vaccinated with Interleukin-2 Gene-Transduced Allogeneic Melanoma Cells

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Human Gene Therapy

• Publication date

  1996-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/hum.1996.7.16-1955PMID 8930655
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance

  2004cited by this paper
• Cytokine gene transduction in the immunotherapy of cancer.

  1997cited by this paper
• Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma.

  1996cited by this paper
• Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy.

  1996cited by this paper
• Multiple HLA-A alleles can present an immunodominant peptide of the human melanoma antigen Melan-A/MART-1 to a peptide-specific HLA-A*0201+ cytotoxic T cell line.

  1996cited by this paper
• Somatic gene therapy of human melanoma: preclinical studies and early clinical trials.

  1995cited by this paper
• Paracrine cytokine adjuvants in cancer immunotherapy.

  1995cited by this paper
• Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15.

  1995cited by this paper
• Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination.

  1995influential reference
• Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance.

  1995cited by this paper
• HLA class II‐restricted recognition of common tumor epitopes on human melanoma cells by CD4+ melanoma‐infiltrating lymphocytes

  1995cited by this paper
• Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.

  1995cited by this paper
• Rejection of mouse melanoma elicited by local secretion of interleukin‐2: Implicating macrophages without T cells or natural killer cells in tumor rejection

  1995cited by this paper
• Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine. Assessment of critical cellular and molecular parameters.

  1995cited by this paper
• From defined human tumor antigens to effective immunization?

  1995cited by this paper
• Interleukin-Gene-Transduced Human Melanoma Cells Efficiently Stimulate MHC-Unrestricted and MHC-Restricted Autologous Lymphocytes

  1994influential reference
• Frequency of cytotoxic T lymphocyte precursors (CTLp) interacting with autologous tumor via the T‐cell receptor: Limiting dilution analysis of specific CTLp in peripheral blood and tumor‐invaded lymph nodes of melanoma patients

  1994cited by this paper
• Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.

  1994cited by this paper
• Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.

  1994cited by this paper
• Transfection of interleukin 2 gene into human melanoma cells augments cellular immune response.

  1993cited by this paper
• Anti‐metastatic vaccination of tumor‐bearing mice with il‐2‐gene‐inserted tumor cells

  1993cited by this paper
• Characterization of human tumor cell lines transduced with the cDNA encoding either tumor necrosis factor alpha (TNF-a) or interleukin-2 (IL-2).

  1993cited by this paper
• Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells

  1992cited by this paper
• Human xenograft-nude mouse model of adoptive immunotherapy with human melanoma-specific cytotoxic T-cells.

  1992cited by this paper
• Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine

  1992cited by this paper
• Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation.

  1991cited by this paper
• Selective changes in expression of HLA class I polymorphic determinants in human solid tumors.

  1989cited by this paper
• The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.

  1989cited by this paper

• Immune Profile Analysis in Peripheral Blood and Tumor in Patients with Malignant Melanoma

  2021cites this paper
• 5 Immunotargeting of Melanoma

  2018cites this paper
• 13 – Cancer Vaccines

  2018cites this paper
• Cancer vaccines

  2015cites this paper
• Oncolytic Virotherapy as Emerging Immunotherapeutic Modality: Potential of Parvovirus H-1

  2014cites this paper
• Tumour Cell-Based Vaccines for the Treatment of Melanoma

  2012cites this paper
• Autologous Versus Allogeneic Cell-Based Vaccines?

  2011cites this paper
• Rational design of polymeric siRNA delivery systems

  2011cites this paper
• Immunotargeting of Melanoma

  2011cites this paper
• Melanoma vaccines: The problems of local immunosuppression.

  2009cites this paper
• Cellular immunotherapy (CI), where have we been and where are we going?

  2009cites this paper
• Application of Cancer Vaccines of IEPOR Series into Clinical Practice of Oncological Establishments of Ukraine

  2009cites this paper
• Systemic therapy of disseminated malignant melanoma: an evidence‐based overview of the state‐of‐the‐art in daily routine

  2007cites this paper
• Mechanisms of local immunosuppression in cutaneous melanoma

  2007cites this paper
• Retroviral-Mediated Gene Transfer for Engineering Tumor-Reactive T-Cells

  2006cites this paper
• Overview of Tumor Cell–Based Vaccines

  2006cites this paper
• Parvovirus H-1-Induced Tumor Cell Death Enhances Human Immune Response In Vitro via Increased Phagocytosis, Maturation, and Cross-Presentation by Dendritic Cells

  2005cites this paper
• On the road to a tumor cell vaccine: 20 years of cellular immunotherapy.

  2004cites this paper
• Vaccines for the Treatment of Cancer

  2004cites this paper
• Gene Therapy of Cancer

  2004cites this paper
• Melanoma Vaccines

  2004cites this paper
• Immunological Aspects of Neoplasia — The Role of the Thymus

  2004cites this paper
• Tumor vaccination with cytokine-encapsulated microspheres.

  2003cites this paper
• Allogeneic breast cancer cell vaccines.

  2003cites this paper
• Zytokine in der Dermatologie

  2003cites this paper
• REDIRECTING T LYMPHOCYTE SPECIFICITY USING T CELL RECEPTOR GENES

  2003cites this paper
• Induction of T Lymphocytes Specific to Human Gastric Cancer Using HLA-A Matched Allogeneic Gastric Tumor Cells

  2003cites this paper
• Immunization of Patients with Malignant Melanoma with Autologous CD34+ Cell-Derived Dendritic Cells Transduced Ex Vivo with a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene: A Phase I Trial

  2003cites this paper
• Recent advances in the cellular immunotherapy of human cancer

  2003cites this paper
• Gene-based therapy of malignant melanoma.

  2002cites this paper
• Cytokine gene-modified cell-based cancer vaccines.

  2002cites this paper
• Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells

  2002cites this paper
• Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell vaccine

  2002cites this paper
• Spontaneous regression of neoplasms: new possibilities for immunotherapy

  2002cites this paper
• Achievements and Perspectives

  2002cites this paper
• Tumor Vaccines

  2002cites this paper
• Gene-based immunotherapy of skin cancers.

  2002cites this paper
• [Cytokines: current status and prospects in the treatment of skin tumors].

  2001cites this paper
• Genetic and Dendritic Cell Vaccination as a Novel Therapy for Melanoma

  2001cites this paper
• Molecular Strategies Interfering with Tumor Progression of Melanoma and Improving Anti-Tumor Immunity

  2001cites this paper
• Zytokine Stand und Perspektiven in der Behandlung von Hauttumoren

  2001cites this paper
• Cancer vaccines.

  2001cites this paper
• Zytokineund Perspektiven in der Behandlung

  2001cites this paper
• Therapeutic vaccines against melanoma and colorectal cancer.

  2001cites this paper
• Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes

  2001cites this paper
• Gene therapy of cancer.

  2000cites this paper
• Construction of new amplifier expression vectors for high levels of IL-2 gene expression.

  2000cites this paper
• Recombinant viruses as a tool for therapeutic vaccination against human cancers.

  2000cites this paper
• Autologous, allogeneic tumor cells or genetically engineered cells as cancer vaccine against melanoma.

  2000cites this paper
• The RB 2 / p 130 Gene : The Latest Weapon in the War against Lung Cancer ? 1

  2000cites this paper
• Vaccination of Melanoma Patients with an Allogeneic, Genetically Modified Interleukin 2-Producing Melanoma Cell Line

  2000cites this paper
• Melanoma vaccines.

  2000cites this paper
• The RB2/p130 gene: the latest weapon in the war against lung cancer?

  2000cites this paper
• Antitumor vaccination: where we stand.

  2000cites this paper
• Immunological Gene Therapy with ex Vivo Gene-Modified Tumor Cells: A Critique and a Reappraisal

  2000cites this paper
• Immunological therapy of human tumors by gene-modified cellular vaccines.

  2000cites this paper
• Immunology and immunotherapy of human cancer: present concepts and clinical developments.

  2000cites this paper
• Cytokine-secreting tumor cell vaccines.

  2000cites this paper
• Gene Therapy for Lung Cancer

  2000cites this paper
• Potential role of tumor vaccines in GI malignancies.

  2000cites this paper
• Chemokines and anti-cancer immunotherapy: anti-tumor effect of EBI1-ligand chemokine (ELC) and secondary lymphoid tissue chemokine (SLC).

  2000cites this paper
• Increased non-major histocompatibility complex-restricted lytic activity in melanoma patients vaccinated with cytokine gene-transfected autologous tumor cells

  2000cites this paper
• Cell-based vaccination against melanoma – background, preliminary results, and perspective

  1999cites this paper
• Gene Therapy with Autologous, Interleukin 2-Secreting Tumor Cells in Patients with Malignant Melanoma

  1999cites this paper
• Gene Transfer Technology in Therapy: Current Applications and Future Goals

  1999cites this paper
• Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine

  1999cites this paper
• Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene

  1999cites this paper
• Cancer gene and immunotherapy: recent developments

  1999cites this paper
• Immunotherapy of Metastatic Malignant Melanoma by a Vaccine Consisting of Autologous Interleukin 2-Transfected Cancer Cells: Outcome of a Phase I Study

  1999cites this paper
• Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine

  1999cites this paper
• L'immunité antitumorale : des concepts à l'immunothérapie active spécifique

  1999cites this paper
• Cell therapy: achievements and perspectives.

  1999cites this paper
• Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumors

  1999cites this paper
• Cancer vaccines.

  1999cites this paper
• Cells and cytokines in immunotherapy and gene therapy of cancer.

  1999cites this paper
• Upon Adoptive Transfer Lymphocytes That Cure Lung Metastases Induces Immunoregulatory Type 2 CD 8 T IL-4-Transduced Tumor Cell Vaccine

  1999cites this paper
• Vaccination of Melanoma Patients with Interleukin 4 Gene-Transduced Allogeneic Melanoma Cells

  1999cites this paper
• Immunothérapie génique du cancer : bilan et perspectives.

  1999cites this paper
• IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.

  1999cites this paper
• The Preuss Foundation Seminar on vaccine therapy for malignant primary brain tumors. February 15-17, 1998, La Jolla, Calif.

  1999cites this paper
• Long-term primary human tumor cell cultures and mixed autologous tumor-lymphocyte cultures for adoptive specific antitumoral immunotherapy.

  1998cites this paper
• The spontaneous regression of neoplasms in mammals: possible mechanisms and their application in immunotherapy.

  1998cites this paper
• Gene therapy for melanoma in humans.

  1998cites this paper
• Molecular Aspects of Cancer and its Therapy

  1998cites this paper
• Investigation of potential problems associated with gene therapy

  1998cites this paper
• Active immunization of metastatic melanoma patients with IL-2 or IL-4 gene transfected, allogeneic melanoma cells.

  1998cites this paper
• Gene transfer technology in therapy: current applications and future goals.

  1998cites this paper
• Recent advances, prospects and problems in designing new strategies for oligonucleotide and gene delivery in therapy.

  1998cites this paper
• Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study

  1998cites this paper
• T-Cell and NK-Mediated Surveillance of Cancer

  1998cites this paper
• Immunogene Therapy of Human Melanoma

  1998cites this paper
• Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects.

  1998cites this paper
• Human Melanoma Cells Transfected with the B7-2 Co-Stimulatory Molecule Induce Tumor-Specific CD8+ Cytotoxic T Lymphocytes In Vitro

  1998cites this paper
• Immunological approach to gene therapy of human cancer: improvements through the understanding of mechanism(s)

  1998cites this paper
• Gene delivery to the epidermis.

  1997cites this paper
• Gene-based strategies for the immunotherapy of cancer

  1997cites this paper
• Cytokine gene transduction in the immunotherapy of cancer.

  1997cites this paper
• Recent Advances in the Treatment of Malignant Melanoma with Gene Therapy

  1997cites this paper
• Vaccine Trials for the Clinician: Prospects for Tumor Antigens.

  1997cites this paper
• Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerability

  1997cites this paper